Home Recalls D-0201-2023
Class II · Moderate risk Terminated Initiated Dec 22, 2022 (4 years ago)
Dexamethasone 16mg/Ml (3ml Vial) Injectable; Dexamethasone 24mg/Ml Injectable…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
What was recalled
DEXAMETHASONE 16MG/ML (3ML VIAL) INJECTABLE; DEXAMETHASONE 24MG/ML INJECTABLE; DEXAMETHASONE-PF- 0.1% (1ML DROPPER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Recalling firm Pharmacy Innovations
Origin PA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0201-2023
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Dexamethasone recalls
See all
Class II · Moderate risk Ongoing Feb 4, 2026
Reason Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were…
Class II · Moderate risk Ongoing Dec 18, 2025
Reason Presence of particulate matter - Glass like particles.
Class II · Moderate risk Ongoing Dec 18, 2025
Reason Presence of particulate matter - Glass like particles.
Class II · Moderate risk Ongoing Aug 13, 2025
Reason Temperature Abuse
Class II · Moderate risk Ongoing Apr 15, 2025
Reason Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024…